Skip to main content
On Demand

Controversies in Thyroidology: The Urgent Threat of Thyroid and Other Hormone-Disrupting Chemicals to Our Health and Future...and What We Can Do About It


Credit Available - See Credits tab below.

Categories:
2020 Summer Series
Duration:
46 Minutes
Format:
Audio and Video


Description

Our fourth of 10 webinars, the American Thyroid Association invites you to join us for our summer series of thyroid education. Programming from the ATA Personalized Approach to Thyroid Disorders and Controversies in Thyroidology cancelled 2020 in-person meetings due to COVID-19 have been transitioned into virtual programs. Learn from leading experts and earn CME and MOC credit all from the comfort of your home or office. 


Program Details

There is no live Q&A with faculty associated with this program. ​This course is available to watch on-demand and receive 0.75 credits until August 31, 2021. View the Accreditation Statement/Credit tab for additional details.

 

Controversies in Thyroidology: The Urgent Threat of Thyroid and Other Hormone-Disrupting Chemicals to Our Health and Future …and What Can We Do About It

 

Faculty: Leonardo Trasande MD, MPP

 

Program Description: Since the report of Herbst and Bern of cancer in young girls exposed to the pharmaceutical diethylstilbestrol in utero, rapidly accumulating evidence suggests that a broader range of synthetic chemicals disrupt hormonal function and thereby contribute to disease and disability across the lifespan.  This evidence has been codified in reports by the Endocrine Society, the International Federation of Gynecologists and Obstetricians, the United Nations Environment Program and the World Health Organization.  Studies in humans show remarkable consistency and affirm initial laboratory studies, particularly for neurodevelopmental toxicity of flame retardant and pesticide exposures, obesity and diabetes as well as male and female reproductive conditions.  The costs of these exposure have been documented to be 163 billion Euro/year in Europe and $340 billion/year in the US.  Exposures to these EDCs are preventable, with health and economic benefits that are substantial and may outweigh the costs of safer alternatives.


Learn more...

Register for the full series of 10 webinars and save on registration fees. To learn more about the webinar series, faculty, accreditation details, program committees, pricing and more, visit the ATA website at https://www.thyroid.org/2020-virtual-program-library/


Who Should Attend

American Thyroid Association virtual programs are open to all healthcare professionals who wish to broaden and update their knowledge of the thyroid gland and thyroid cancer. ATA content is scientific in nature and is intended for researchers and practitioners in thyroidology with interests in the fields of endocrinology, oncology, nuclear medicine, internal medicine, surgery, pathology, radiation oncology, cytology, biology, pharmacology, family medicine and related areas. ATA education is targeted to the full thyroid team who diagnose and treat thyroid disorders (e.g., primary care physicians, nurse practitioners, registered nurses, physician assistants, etc.).

Credits

Accreditation Statement/Credit

Note: A link to evaluate this program and claim credit will be available after purchasing and viewing the full webinar.

 

Disclosure Statement 

  • Dr. Trasande receives honoraria from Audible and Houghton Mifflin as well as grant/research support from the CDC and NIH.
 

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Colorado School of Medicine and the American Thyroid Association®. The University of Colorado School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

 

The University of Colorado School of Medicine designates this enduring material for a maximum of  0.75 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 Medical Knowledge MOC point in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

Successful completion of this CME activity, which includes participation in the evaluation component, enable the participant to earn their required annual part II self-assessment credit in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification (CC) program (formerly known as MOC).  It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of recognizing participation

 

Completion of Learning Assessment by Participant

Credit Disseminated

(CME Certificates sent to Attendee Email provided and/or ABIM MOC Data Uploaded and/or ABOHNS MOC Data Uploaded)

May 29, 2020 – August 31, 2020 

September 15, 2020

September 1, 2020 – November 30, 2020

December 15, 2020

December 1, 2020 – February 28, 2021

March 15, 2021

March 1, 2021 – May 31, 2021

June 15, 2021

June 1, 2021 – August 31, 2021

September 15, 2021



Webinar 1: AMA PRA Category 1 Credit™ The University of Colorado School of Medicine designates this other activity (combination of live and enduring activities) for a maximum of  0.75 AMA PRA Category 1 CreditTMPhysicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Leonardo Trasande's Profile

Leonardo Trasande Related Seminars and Products


Leonardo Trasande, MD, MPP is an internationally renowned leader in environmental health.  His research focuses on identifying the role of environmental exposures in childhood obesity and cardiovascular risks and documenting the economic costs for policy makers of failing to prevent diseases of environmental origin in children proactively.  He also holds appointments in the Wagner School of Public Service and NYU’s College of Global Public Health.  He is perhaps best known for a series of studies published in Lancet Diabetes and Endocrinology and the Journal of Clinical Endocrinology and Metabolism that document disease costs due to endocrine disrupting chemicals in the US and Europe of $340 billion and €163 billion annually, respectively. Dr. Trasande leads one of 35 centers across the country as part of the National Institute of Health’s Environmental Influences on Child Health Outcomes program.  He is leveraging the NYU Children’s Health and Environment Study as well as another birth cohort to examine phthalates, bisphenols, organophosphate pesticides and polycyclic aromatic hydrocarbons and their effects on fetal as well as postnatal growth and early cardiovascular and renal risks.  These two cohorts are part of a larger initiative nationally to identify preventable and environmental factors that influence child health and disease. After receiving his bachelor, medical and public policy degrees from Harvard, he completed the Boston Combined Residency in Pediatrics and a legislative fellowship in the Office of Senator Hillary Rodham Clinton.


Accreditation Statement/Credit

Note: A link to evaluate this program and claim credit will be available after purchasing and viewing the full webinar.

 

Disclosure Statement 

  • Dr. Trasande receives honoraria from Audible and Houghton Mifflin as well as grant/research support from the CDC and NIH.
 

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the University of Colorado School of Medicine and the American Thyroid Association®. The University of Colorado School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

 

The University of Colorado School of Medicine designates this enduring material for a maximum of  0.75 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

 

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 Medical Knowledge MOC point in the American Board of Internal Medicine (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

 

Successful completion of this CME activity, which includes participation in the evaluation component, enable the participant to earn their required annual part II self-assessment credit in the American Board of Otolaryngology – Head and Neck Surgery’s (ABOHNS) Continuing Certification (CC) program (formerly known as MOC).  It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of recognizing participation

 

Completion of Learning Assessment by Participant

Credit Disseminated

(CME Certificates sent to Attendee Email provided and/or ABIM MOC Data Uploaded and/or ABOHNS MOC Data Uploaded)

May 29, 2020 – August 31, 2020 

September 15, 2020

September 1, 2020 – November 30, 2020

December 15, 2020

December 1, 2020 – February 28, 2021

March 15, 2021

March 1, 2021 – May 31, 2021

June 15, 2021

June 1, 2021 – August 31, 2021

September 15, 2021